Company intelligence

Axiom AIOSciences

BiotechActive

Is this your company? Get featured or correct your listing →

Suggest a correction

We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. US Biotech Axiom Chooses Hong Kong Listing Over Wall StreetUS biotech firm Axiom AIOSciences is listing in Hong Kong before pursuing a US listing, a reversal of the usual playbook that reflects how competitive Asian capital markets have become for biotech and AI-adjacent listings.→

Coverage Timeline

newest first
  1. Jul 22, 2026IPOUS Biotech Axiom Chooses Hong Kong Listing Over Wall Street→

All Coverage

IPO

US Biotech Axiom Chooses Hong Kong Listing Over Wall Street

Illustration for: US Biotech Axiom Chooses Hong Kong Listing Over Wall Street
IPO

US Biotech Axiom Chooses Hong Kong Listing Over Wall Street

US biotech firm Axiom AIOSciences is listing in Hong Kong before pursuing a US listing, a reversal of the usual playbook that reflects how competitive Asian capital markets have become for biotech and AI-adjacent listings.

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsIambic TherapeuticsApnimedRetension PharmaceuticalsEli Lilly